Management of Prolonged Seizures and Status Epilepticus in Childhood: A Systematic Review

Abstract

Pediatric prolonged seizures and status epilepticus are medical emergencies necessitating immediate life-support and seizure-control measures. A systematic review of published data on the management of prolonged seizures and status epilepticus showed that buccal midazolam was significantly more effective than rectal diazepam, reaching a seizure-control rate of 70% and recurrence rate of 8%. Intranasal lorazepam was as effective as intramuscular paraldehyde in a cost-restrained setting. In refractory status epilepticus, both intravenous midazolam and valproate were equally effective to intravenous diazepam, with valproate exhibiting significantly faster seizure cessation and safer profile than diazepam, even in infancy. In conclusion, buccal midazolam is efficacious and safe thanks to its convenient route of administration, which may serve as first-line in the treatment of prolonged seizures. Intranasal lorazepam is an effective, easy-to-use, and safe drug for prolonged seizures. Intravenous valproate exhibits favorable efficacy and safety profile as third-line in status epilepticus, refractory to diazepam and phenytoin.

Keywords

status epilepticus prolonged seizures treatment midazolam lorazepam valproate systematic review refractory buccal intranasal

Get full access to this article

View all access options for this article.

References

Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus: treatment of convulsive status epilepticus. JAMA. 1993;270:854-859.

Berg AT , Shinnar S. , Levy SR , Testa FM Status epilepticus in children with newly diagnosed epilepsy. Ann Neurol. 1999;45: 618-623.

Lothman E. The biochemical basis and pathophysiology of status epilepticus. Neurology. 1990;40(suppl 2):13-23.

Bleck TP Convulsive disorders: status epilepticus. Clin Neuro-pharmacol . 1991;14:191-198.

Lowenstein DH , Alldredge BK Status epilepticus. N Engl J Med. 1998;338:970-976.

Treiman DM , Meyers PD , Walton NY , et al. A comparison of four treatments for generalized convulsive status epilepticus: Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339:792-798.

Lowenstein DH , Bleck T. , Macdonald RL It's time to revise the definition of status epilepticus. Epilepsia. 1999;40:120-122.

Wasterlain CG Definition and classification of status epilepticus. The International Meeting on Status Epilepticus, Santa Monica, CA; 1997 (abstract).

Meldrum BS The revised operational definition of generalised tonic-clonic status epilepticus in adults. Epilepsia. 1999;40: 123-124.

10.

Shorvon S. The management of status epilepticus. J Neurol Neurosurg Psychiatry . 2001;70(suppl 2):1122-1127.

11.

Chen JW , Wasterlain CG Status epilepticus: pathophysiology and management in adults. Lancet Neurol. 2006;5:246-256.

12.

DeLorenzo RJ , Garnett LK , Towne AR , et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes . Epilepsia. 1999;40:164-169.

13.

Eriksson K. , Metsaranta P. , Huhtala H. , Auvinen A. , Kuusela AL , Koivikko M. Treatment delay and the risk of prolonged status epilepticus. Neurology. 2005;65:1316-1318.

14.

Mazarati AM , Baldwin RA , Sankar R. , Wasterlain CG Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus . Brain Res. 1998;814:179-185.

15.

Kapur J. , Macdonald RL Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci . 1997;17:7532-7540.

16.

Novorol CL , Chin RF , Scott RC Outcome of convulsive status epilepticus: a review. Arch Dis Child. 2007;92:948-951.

17.

Raspall-Chaure M. , Chin RF , Neville BG , Scott RC Outcome of paediatric convulsive status epilepticus: a systematic review. Lancet Neurol. 2006;5:769-779.

18.

Shorvon SD Definition, classification and frequency of status epilepticus. In: Shorvon SD , ed. Status Epilepticus: Its Clinical Features and Treatment in Children and Adults. Cambridge : Cambridge University Press; 1994 :21-30.

19.

Meierkord H. , Holtkamp M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol. 2007;6:329-339.

20.

Krumholz A. , Sung GY , Fisher RS , Barry E. , Bergey GK , Grattan LM Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology. 1995;45: 1499-1504.

21.

Kaplan PW Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol. 1999;16:341-352.

22.

Chamberlain JM , Altieri MA , Futterman C. , Young GM , Ochsenschlager DW , Waisman Y. A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr Emerg Care . 1997;13:92-94.

23.

Scott RC , Besag FM , Neville BG Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet. 1999;353:623-626.

24.

Lahat E. , Goldman M. , Barr J. , Bistritzer T. , Berkovitch M. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomized study. BMJ. 2000;321:83-86.

25.

Ahmad S. , Ellis JC , Kamwendo H. , Molyneux E. Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial. Lancet. 2006;367:1591-1597.

26.

Mpimbaza A. , Ndeezi G. , Staedke S. , Rosenthal PJ , Byarugaba J. Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial. Pediatrics . 2008;121:e58-e64.

27.

Singhi S. , Murthy A. , Singhi P. , Jayashree M. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol. 2002;17:106-110.

28.

Mehta V. , Singhi P. , Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial . J Child Neurol. 2007;22:1191-1197.

29.

Agarwal P. , Kumar N. , Chandra R. , Gupta G. , Antony AR , Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus . Seizure. 2007;16:527-532.

30.

Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA. 1993;270:854-859.

31.

Chin RF , Neville BG , Peckham C. , Bedford H. , Wade A. , Scott RC , for the NLSTEPSS Collaborative Group. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006;368:222-229.

32.

Metsaranta P. , Koivikko M. , Peltola J. , Eriksson K. Outcome after prolonged convulsive seizures in 186 children: low morbidity, no mortality . Dev Med Child Neurol. 2004;46:4-8.

33.

Scott RC Buccal midazolam as rescue therapy for acute seizures. Lancet Neurol. 2005;4:592-593.

34.

Wilson MT , Macleod S. , O'Regan ME Nasal/buccal midazolam use in the community. Arch Dis Child . 2004;89: 50-51.

35.

Schwagmeier R. , Alincic S. , Striebel HW Midazolam pharmacocinetics following intravenous and buccal administration. Br J Clin Pharmacol. 1998;46:203-206.

36.

Walberg EJ , Wills RJ , Eckhert J. Plasma concentrations of midazolam in children following intranasal administration . Anesthesiology. 1991;40:661-667.

37.

Karl HW , Rosenberger JL , Larach MG , Ruffle JM Transmucosal administration of midazolam for premedication of pediatric patients. Comparison of the nasal and sublingual routes. Anesthesiology . 1993;55:176-179.

38.

Wermeling DPH , Miller JL , Archer SM , Manaligod JM , Rudy AC Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration. J Clin Pharmacol. 2001;41:1225-1231.

39.

Scott RC , Besag FM , Boyd SG , Berry D. , Neville BG Buccal absorption of midazolam: pharmacokinetics and EEG pharmacodynamics . Epilepsia. 1998;39:290-294.

40.

Barsan WG Intramuscular midazolam versus intravenous lorazepam in the pre-hospital treatment of status epilepticus (the RAMPART trial) Project Summary. http://www.nett.umich.edu/nett/files/rampart_summary_format.pdf . Accessed January 9, 2008.

41.

Yu KT , Mills S. , Thompson N. , Cunanan C. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia. 2003;44:724-726.

42.

Waterhouse E. Intravenous valproate for pediatric status epilepticus. Epilepsy Curr. 2003;3:208-209.

43.

Uberall MA , Trollmann R. , Wunsiedler U. , Wenzel D. Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology. 2000;54:2188-2189.

44.

Hovinga CA , Chicella MF , Rose DF , Eades SK , Dalton JT , Phelps SJ Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus. Ann Pharmacother. 1999;33:579-584.

45.

Valproate: Summary Product Characteristics (SPCs). http://www.medicines.org.uk. Accessed January 9, 2008.

46.

Appleton R. , Macleod S. , Martland T. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev. 2008 ;3:CD001905.